Nvwm, LLC Abb Vie Inc. Transaction History

Nvwm, LLC

$382 Million
Q3 2024

A detailed history of Nvwm, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Nvwm, LLC holds 12,170 shares of ABBV stock, worth $2.09 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares

12,170

Previous 12,316 1.19%

Holding current value

$2.09 Million

Previous $2.11 Million 13.78%

% of portfolio

0.63%

Previous 0.58%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$163.84 - $199.33 $23,920 - $29,102	-146 Reduced 1.19%	12,170 $2.4 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $266,084 - $310,726	1,719 Added 16.22%	12,316 $2.11 Million
Q1 2024 May 06, 2024	SELL	$159.82 - $182.1 $28,288 - $32,231	-177 Reduced 1.64%	10,597 $1.93 Million
Q4 2023 Feb 07, 2024	SELL	$137.6 - $154.97 $397,526 - $447,708	-2,889 Reduced 21.14%	10,774 $1.67 Million
Q3 2023 Oct 30, 2023	BUY	$133.59 - $154.65 $2,003 - $2,319	15 Added 0.11%	13,663 $2.04 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $942,013 - $1.17 Million	-7,109 Reduced 34.25%	13,648 $1.84 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $39,189 - $45,132	271 Added 1.32%	20,757 $3.31 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $29,183 - $34,998	-211 Reduced 1.02%	20,486 $3.31 Million
Q3 2022 Nov 15, 2022	BUY	$134.21 - $153.93 $693,463 - $795,356	5,167 Added 33.27%	20,697 $2.78 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $35,643 - $45,314	259 Added 1.7%	15,530 $2.38 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $659,372 - $818,095	-4,996 Reduced 24.65%	15,271 $2.48 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $429 - $543	-4 Reduced 0.02%	20,267 $2.74 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $51,604 - $58,578	485 Added 2.45%	20,271 $2.19 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $27,670 - $30,826	-263 Reduced 1.31%	19,786 $2.23 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $97,389 - $107,214	952 Added 4.99%	20,049 $2.17 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $17,868 - $24,124	222 Added 1.18%	19,097 $2.05 Million
Q3 2020 Dec 10, 2020	BUY	$85.91 - $100.83 $50,171 - $58,884	584 Added 3.19%	18,875 $1.65 Million
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $1.19 Million - $1.59 Million	16,202 Added 775.59%	18,291 $1.8 Million
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $49,278 - $74,711	764 Added 57.66%	2,089 $159,000
Q3 2019 Nov 08, 2019	SELL	$62.98 - $75.72 $2.11 Million - $2.54 Million	-33,527 Reduced 96.2%	1,325 $100,000
Q3 2019 Oct 29, 2019	BUY	$62.98 - $75.72 $2.19 Million - $2.64 Million	34,852 New	34,852 $134,000
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $26,999 - $31,776	-350 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $2,101 - $2,592	-27 Reduced 7.16%	350 $32,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $474,068 - $527,014	-5,332 Reduced 93.4%	377 $36,000
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $7,182 - $8,498	80 Added 1.42%	5,709 $529,000
Q1 2018 May 17, 2018	BUY	$92.01 - $123.21 $484,524 - $648,823	5,266 Added 1450.69%	5,629 $514,000
Q4 2017 Mar 15, 2018	BUY	$89.56 - $98.21 $32,510 - $35,650	363	363 $35,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account